Yeast Surface Display

Therapeutic Monoclonal Antibodies: From Bench to Clinic

Volumn , Issue , 2009, Pages 213-237

  Lahti, Jennifer L ^a   Cochran, Jennifer R ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Engineering antibodies for affinity, specificity, stability and expression; Screening yeast displayed antibody libraries; Yeast surface display

Indexed keywords

EID: 84855570112     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470485408.ch9     Document Type: Chapter

References (84)

1. Blaise, L., A. Wehnert, M.P. Steukers, T. van den Beucken, H.R. Hoogenboom, and S.E. Hufton. 2004. Construction and diversification of yeast cell surface displayed libraries by yeast mating: Application to the affinity maturation of Fab antibody fragments. Gene 342(2):211-218.
2. Boder, E.T., K.S. Midelfort, and K.D. Wittrup. 2000. Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity. Proc. Natl. Acad. Sci. USA 97(20):10701-10705.
3. Boder, E.T., and K.D. Wittrup. 1997. Yeast surface display for screening combinatorial polypeptide libraries. Nature Biotechnol. 15(6):553-557.
4. Boder, E.T., and K.D. Wittrup. 1998. Optimal screening of surface-displayed polypeptide libraries. Biotechnol. Prog. 14(1):55-62.
5. Bowley, D.R., A.F. Labrijn, M.B. Zwick, and D.R. Burton. 2007. Antigen selection from an HIV-1 immune antibody library displayed on yeast yields many novel antibodies compared to selection from the same library displayed on phage. Protein Eng. Des. Sel. 20(2):81-90.
6. Cappellaro, C., C. Baldermann, R. Rachel, and W. Tanner. 1994. Mating type-specific cell-cell recognition of Saccharomyces cerevisiae: Cell wall attachment and active sites of a-and alpha-agglutinin. EMBO J. 13(20):4737-4744.
7. Chao, G., J.R. Cochran, and K.D. Wittrup. 2004. Fine epitope mapping of anti-epidermal growth factor receptor antibodies through random mutagenesis and yeast surface display. J. Mol. Biol. 342(2):539-550.
8. Chao, G., W.L. Lau, B.J. Hackel, S.L. Sazinsky, S.M. Lippow, and K.D. Wittrup. 2006. Isolating and engineering human antibodies using yeast surface display. Nature Protoc. 1(2):755-768.
9. Chowdhury, P.S., and H. Wu. 2005. Tailor-made antibody therapeutics. Methods 36(1):11-24.
10. Cochran, J.R., Y.S. Kim, S.M. Lippow, B. Rao, and K.D. Wittrup. 2006. Improved mutants from directed evolution are biased to orthologous substitutions. Protein Eng. Des. Sel. 19(6):245-253.
11. Cochran, J.R., Y.S. Kim, M.J. Olsen, R. Bhandari, and K.D. Wittrup. 2004. Domain-level antibody epitope mapping through yeast surface display of epidermal growth factor receptor fragments. J. Immunol. Methods 287(1-2):147-158.
12. Colby, D.W., Y. Chu, J.P. Cassady, et al. 2004a. Potent inhibition of huntingtin aggregation and cytotoxicity by a disulfide bond-free single-domain intracellular antibody. Proc. Natl. Acad. Sci. USA 101(51):17616-17621.
13. Colby, D.W., P. Garg, T. Holden, et al. 2004b. Development of a human light chain variable domain (V(L)) intra-cellular antibody specific for the amino terminus of huntingtin via yeast surface display. J. Mol. Biol. 342(3):901-912.
14. Colby, D.W., B.A. Kellogg, C.P. Graff, Y.A. Yeung, J.S. Swers, and K.D. Wittrup. 2004c. Engineering antibody affinity by yeast surface display. Methods Enzymol. 388:348-358.
15. Ellgaard, L., and A. Helenius. 2003. Quality control in the endoplasmic reticulum. Nature Rev. Mol. Cell. Biol. 4(3):181-191.
16. Feldhaus, M., and R. Siegel. 2004a. Flow cytometric screening of yeast surface display libraries. Methods Mol. Biol. 263:311-332.
17. Feldhaus, M.J., and R.W. Siegel. 2004b. Yeast display of antibody fragments: A discovery and characterization platform. J. Immunol. Methods 290(1-2):69-80.
18. Feldhaus, M.J., R.W. Siegel, L.K. Opresko, et al. 2003. Flow-cytometric isolation of human antibodies from a nonimmune Saccharomyces cerevisiae surface display library. Nature Biotechnol. 21(2):163-170.
19. Furukawa, H., R. Shimojyo, N. Ohnishi, H. Fukuda, and A. Kondo. 2003. Affinity selection of target cells from cell surface displayed libraries: A novel procedure using thermo-responsive magnetic nanoparticles. Appl. Microbiol. Biotechnol. 62(5-6):478-483.
20. Gai, S.A., and K.D. Wittrup. 2007. Yeast surface display for protein engineering and characterization. Curr. Opin. Struct. Biol. 17(4):467-473.
21. Garcia-Rodriguez, C., R. Levy, J.W. Arndt, et al. 2007. Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxin. Nature Biotechnol. 25(1):107-116.
22. Graff, C.P., K. Chester, R. Begent, and K.D. Wittrup. 2004. Directed evolution of an anti-carcinoembryonic antigen scFv with a 4-day monovalent dissociation half-time at 37 degrees C. Protein Eng. Des. Sel. 17(4):293-304.
23. Graff, C.P., and K.D. Wittrup. 2003. Theoretical analysis of antibody targeting of tumor spheroids: Importance of dosage for penetration, and affinity for retention. Cancer Res. 63(6):1288-1296.
24. Griffin, M.D., P.O. Holman, Q. Tang, et al. 2001. Development and applications of surface-linked single chain antibodies against T-cell antigens. J. Immunol. Methods 248(1-2):77-90.
25. Hammond, C., and A. Helenius. 1995. Quality control in the secretory pathway. Curr. Opin. Cell Biol. 7(4):523-529.
26. Harmsen, M.M., and H.J. De Haard. 2007. Properties, production, and applications of camelid single-domain antibody fragments. Appl. Microbiol. Biotechnol. 77(1):13-22.
27. Holler, P.D., P.O. Holman, E.V. Shusta, S. O'Herrin, K.D. Wittrup, and D.M. Kranz. 2000. In vitro evolution of a T cell receptor with high affinity for peptide/MHC. Proc. Natl. Acad. Sci. USA 97(10):5387-5392.
28. Hoogenboom, H.R. 2005. Selecting and screening recombinant antibody libraries. Nature Biotechnol. 23(9):1105-1116.
29. Huang, D., and E.V. Shusta. 2005. Secretion and surface display of green fluorescent protein using the yeast Saccharomyces cerevisiae. Biotechnol. Prog. 21(2):349-357.
30. Huang, J., A. Koide, K.W. Nettle, G.L. Greene, and S. Koide. 2006. Conformation-specific affinity purification of proteins using engineered binding proteins: Application to the estrogen receptor. Protein Expr. Purif. 47(2):348-354.
31. Johns, T.G., T.E. Adams, J.R. Cochran, et al. 2004. Identification of the epitope for the epidermal growth factor receptor-specific monoclonal antibody 806 reveals that it preferentially recognizes an untethered form of the receptor. J. Biol. Chem. 279(29):30375-30384.
32. Karatan, E., M. Merguerian, Z. Han, M.D. Scholle, S. Koide, and B.K. Kay. 2004. Molecularrecognition properties of FN3 monobodies that bind the Src SH3 domain. Chem. Biol. 11(6):835-844.
33. Kieke, M.C., B.K. Cho, E.T. Boder, D.M. Kranz, and K.D. Wittrup. 1997. Isolation of anti-T cell receptor scFv mutants by yeast surface display. Protein Eng. 10(11):1303-1310.
34. Kim, Y.S., R. Bhandari, J.R. Cochran, J. Kuriyan, and K.D. Wittrup. 2006. Directed evolution of the epidermal growth factor receptor extracellular domain for expression in yeast. Proteins 62(4):1026-1035.
35. Koide, A., S. Abbatiello, L. Rothgery, and S. Koide. 2002. Probing protein conformational changes in living cells by using designer binding proteins: Application to the estrogen receptor. Proc. Natl. Acad. Sci. USA 99(3):1253-1258.
36. Koide, A., C.W. Bailey, X. Huang, and S. Koide. 1998. The fibronectin type III domain as a scaffold for novel binding proteins. J. Mol. Biol. 284(4):1141-1151.
37. Koide, A., and S. Koide. 2007. Monobodies: Antibody mimics based on the scaffold of the fibronectin type III domain. MethodsMol. Biol. 352:95-109.
38. Kondo, A., and M. Ueda. 2004. Yeast cell-surface display: Applications of molecular display. Appl. Microbiol. Biotechnol. 64(1):28-40.
39. Kowalski, J.M., R.N. Parekh, J. Mao, and K.D. Wittrup. 1998. Protein folding stability can determine the efficiency of escape from endoplasmic reticulum quality control. J. Biol. Chem. 273(31):19453-19458.
40. Kowalski, J.M., R.N. Parekh, and K.D. Wittrup. 1998. Secretion efficiency in Saccharomyces cerevisiae of bovine pancreatic trypsin inhibitor mutants lacking disulfide bonds is correlated with thermodynamic stability. Biochemistry 37(5):1264-1273.
41. Lee, H.W., S.H. Lee, K.J. Park, J.S. Kim, M.H. Kwon, and Y.S. Kim. 2006. Construction and characterization of a pseudo-immune human antibody library using yeast surface display. Biochem. Biophys. Res. Commun. 346(3):896-903.
42. Levy, R., C.M. Forsyth, S.L. LaPorte, I.N. Geren, L.A. Smith, and J.D. Marks. 2007. Fine and domain-level epitope mapping of botulinum neurotoxin type A neutralizing antibodies by yeast surface display. J. Mol. Biol. 365(1):196-210.
43. Li, S., K.R. Schmitz, P.D. Jeffrey, J.J. Wiltzius, P. Kussie, and K.M. Ferguson. 2005. Structural basis for inhibition of the epidermal growth factor receptor by cetuximab. Cancer Cell 7(4):301-311.
44. Lin, Y., T. Tsumuraya, T. Wakabayashi, et al. 2003. Display of a functional hetero-oligomeric catalytic antibody on the yeast cell surface. Appl. Microbiol. Biotechnol. 62(2-3):226-232.
45. Lipovsek, D., E. Antipov, K.A. Armstrong, et al. 2007a. Selection of horseradish peroxidase variants with enhanced enantioselectivity by yeast surface display. Chem. Biol. 14(10):1176-1185.
46. Lipovsek, D., S.M. Lippow, B.J. Hackel, et al. 2007b. Evolution of an interloop disulfide bond in high-affinity antibody mimics based on fibronectin type III domain and selected by yeast surface display: Molecular convergence with single-domain camelid and shark antibodies. J. Mol. Biol. 368(4):1024-1041.
47. Ma, H., S. Kunes, P.J. Schatz, and D. Botstein. 1987. Plasmid construction by homologous recombination in yeast. Gene 58(2-3):201-216.
48. Midelfort, K.S., H.H. Hernandez, S.M. Lippow, B. Tidor, C.L. Drennan, and K.D. Wittrup. 2004. Substantial energetic improvement with minimal structural perturbation in a high affinity mutant antibody. J. Mol. Biol. 343(3):685-701.
49. Midelfort, K.S., and K.D. Wittrup. 2006. Context-dependent mutations predominate in an engineered high-affinity single chain antibody fragment. Protein Sci. 15(2):324-334.
50. Miller, T.W., and A. Messer. 2005. Intrabody applications in neurological disorders: Progress and future prospects. Mol. Ther. 12(3):394-401.
51. Mohr, L., A. Yeung, C. Aloman, D. Wittrup, and J.R. Wands. 2004. Antibody-directed therapy for human hepato-cellular carcinoma. Gastroenterology 127(5, Suppl 1):S225-231.
52. Nissim, A., and Y. Chernajovsky. 2008. Historical development of monoclonal antibody therapeutics. Handb. Exp. Pharmacol. 181:3-18.
53. Oliphant, T., M. Engle, G.E. Nybakken, et al. 2005. Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nature Med. 11(5):522-530.
54. Orr, B.A., L.M. Carr, K.D. Wittrup, E.J. Roy, and D.M. Kranz. 2003. Rapid method for measuring ScFv thermal stability by yeast surface display. Biotechnol. Prog. 19(2):631-638.
55. Park, S., Y. Xu, X.F. Stowell, F. Gai, J.G. Saven, and E.T. Boder. 2006. Limitations of yeast surface display in engineering proteins of high thermostability. Protein Eng. Des. Sel. 19(5):211-217.
56. Parker, M.H., Y. Chen, F. Danehy, et al. 2005. Antibody mimics based on human fibronectin type three domain engineered for thermostability and high-affinity binding to vascular endothelial growth factor receptor two. Protein Eng. Des. Sel. 18(9):435-444.
57. Piatesi, A., S.W. Howland, J.A. Rakestraw, et al. 2006. Directed evolution for improved secretion of cancer-testis antigen NY-ESO-1 from yeast. Protein Expr. Purif. 48(2):232-242.
58. Proba, K., A. Worn, A. Honegger, and A. Pluckthun. 1998. Antibody scFv fragments without disulfide bonds made by molecular evolution. J. Mol. Biol. 275(2):245-253.
59. Rakestraw, A., and K.D. Wittrup. 2006. Contrasting secretory processing of simultaneously expressed heterologous proteins in Saccharomyces cerevisiae. Biotechnol. Bioeng. 93(5):896-905.
60. Rapley, R. 1995. The biotechnology and applications of antibody engineering. Mol. Biotechnol. 3(2):139-154.
61. Razai, A., C. Garcia-Rodriguez, J. Lou, et al. 2005. Molecular evolution of antibody affinity for sensitive detection of botulinum neurotoxin type A. J. Mol. Biol. 351(1):158-169.
62. Richman, S.A., S.J. Healan, K.S. Weber, et al. 2006. Development of a novel strategy for engineering high-affinity proteins by yeast display. Protein Eng. Des. Sel. 19(6):255-264.
63. Sblattero, D., and A. Bradbury. 2000. Exploiting recombination in single bacteria to make large phage antibody libraries. Nature Biotechnol. 18(1):75-80.
64. Scholler, N., B. Garvik, T. Quarles, S. Jiang, and N. Urban. 2006. Method for generation of in vivo biotinylated recombinant antibodies by yeast mating. J. Immunol. Methods 317(1-2):132-143.
65. Schweickhardt, R.L., X. Jiang, L.M. Garone, and W.H. Brondyk. 2003. Structure-expression relationship of tumor necrosis factor receptor mutants that increase expression. J. Biol. Chem. 278(31):28961-28967.
66. Shusta, E.V., P.D. Holler, M.C. Kieke, D.M. Kranz, and K.D. Wittrup. 2000. Directed evolution of a stable scaffold for T-cell receptor engineering. Nature Biotechnol. 18(7):754-759.
67. Shusta, E.V., M.C. Kieke, E. Parke, D.M. Kranz, and K.D. Wittrup. 1999. Yeastpolypeptide fusion surface display levels predict thermal stability and soluble secretion efficiency. J. Mol. Biol. 292(5):949-956.
68. Shusta, E.V., R.T. Raines, A. Pluckthun, and K.D. Wittrup. 1998. Increasing the secretory capacity of Saccharomyces cerevisiae for production of single-chain antibody fragments. Nature Biotechnol. 16(8):773-777.
69. Siegel, R.W., J.R. Coleman, K.D. Miller, and M.J. Feldhaus. 2004. High efficiency recovery and epitope-specific sorting of an scFv yeast display library. J. Immunol. Methods 286(1-2):141-153.
70. Skerra, A. 2007. Alternative non-antibody scaffolds for molecular recognition. Curr. Opin. Biotechnol. 18(4):295-304.
71. Swers, J.S., B.A. Kellogg, and K.D. Wittrup. 2004. Shuffled antibody libraries created by in vivo homologous recombination and yeast surface display. Nucleic Acids Res. 32(3): e36.
72. VanAntwerp, J.J., and K.D. Wittrup. 2000. Fine affinity discrimination by yeast surface display and flow cytometry. Biotechnol, Prog. 16(1):31-37.
73. van den Beucken, T., H. Pieters, M. Steukers, et al. 2003. Affinity maturation of Fab antibody fragments by fluorescent-activated cell sorting of yeast-displayed libraries. FEBS Lett. 546(2-3):288-294.
74. van der Linden, R.H., B. de Geus, G.J. Frenken, H. Peters, and C.T. Verrips. 2000. Improved production and function of llama heavy chain antibody fragments by molecular evolution. J. Biotechnol. 80(3):261-270.
75. Wang, X.X., Y.K. Cho, and E.V. Shusta. 2007. Mining a yeast library for brain endothelial cell-binding antibodies. Nature Methods 4(2):143-145.
76. Wang, X.X., and E.V. Shusta. 2005. The use of scFv-displaying yeast in mammalian cell surface selections. J. Immunol. Methods 304(1-2):30-42.
77. Waterhouse, P., A.D. Griffiths, K.S. Johnson, and G. Winter. 1993. Combinatorial infection and in vivo recombination: A strategy for making large phage antibody repertoires. Nucleic Acids Res. 21(9):2265-2266.
78. Weaver-Feldhaus, J.M., J. Lou, J.R. Coleman, R.W. Siegel, J.D. Marks, and M.J. Feldhaus. 2004. Yeast mating for combinatorial Fab library generation and surface display. FEBS Lett. 564(1-2):24-34.
79. Weaver-Feldhaus, J.M., K.D. Miller, M.J. Feldhaus, and R.W. Siegel. 2005. Directed evolution for the development of conformation-specific affinity reagents using yeast display. Protein Eng. Des. Sel. 18(11):527-536.
80. Worn, A., A. Auf der Maur, D. Escher, A. Honegger, A. Barberis, and A. Pluckthun. 2000. Correlation between in vitro stability and in vivo performance of anti-GCN4 intrabodies as cytoplasmic inhibitors. J. Biol. Chem. 275(4):2795-2803.
81. Worn, A., and A. Pluckthun. 2001. Stability engineering of antibody single-chain Fv fragments. J. Mol. Biol. 305(5):989-1010.
82. Xu, L., P. Aha, K. Gu, et al. 2002. Directed evolution of high-affinity antibody mimics using mRNA display. Chem. Biol. 9(8):933-942.
83. Yeung, Y.A., and K.D. Wittrup. 2002. Quantitative screening of yeast surface-displayed polypeptide libraries by magnetic bead capture. Biotechnol. Prog. 18(2):212-220.
84. Zhou, Y., D.C. Drummond, H. Zou, et al. 2007. Impact of single-chain Fv antibody fragment affinity on nano-particle targeting of epidermal growth factor receptor-expressing tumor cells. J. Mol. Biol. 371(4):934-947.